<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B15D18A8-63A8-4893-8F4A-0A3BE4D2C583"><gtr:id>B15D18A8-63A8-4893-8F4A-0A3BE4D2C583</gtr:id><gtr:name>Karus Therapeutics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89E1FCBF-B158-4149-9AF3-3DD1AE2857F2"><gtr:id>89E1FCBF-B158-4149-9AF3-3DD1AE2857F2</gtr:id><gtr:name>Nikon</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/41EDECF5-7D7B-4C24-B989-1C9879B5F548"><gtr:id>41EDECF5-7D7B-4C24-B989-1C9879B5F548</gtr:id><gtr:name>ASH Biotech</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B15D18A8-63A8-4893-8F4A-0A3BE4D2C583"><gtr:id>B15D18A8-63A8-4893-8F4A-0A3BE4D2C583</gtr:id><gtr:name>Karus Therapeutics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89E1FCBF-B158-4149-9AF3-3DD1AE2857F2"><gtr:id>89E1FCBF-B158-4149-9AF3-3DD1AE2857F2</gtr:id><gtr:name>Nikon</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/41EDECF5-7D7B-4C24-B989-1C9879B5F548"><gtr:id>41EDECF5-7D7B-4C24-B989-1C9879B5F548</gtr:id><gtr:name>ASH Biotech</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/ADEE92B8-DF3D-4F42-9B88-8FE07AE38936"><gtr:id>ADEE92B8-DF3D-4F42-9B88-8FE07AE38936</gtr:id><gtr:firstName>Marysia</gtr:firstName><gtr:surname>Placzek</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_G0802527"><gtr:id>CD309051-8E76-4A4A-8B64-05B48790B2D3</gtr:id><gtr:title>Development and Use of a Zebrafish Screening Model at Sheffield University</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_G0802527</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1538697</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nikon</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Customized microscope (SB)</gtr:description><gtr:id>CB150854-5ADF-470D-92C7-95C6E353CD38</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>dkGha4H5AAR-1</gtr:outcomeId><gtr:partnerContribution>Collaborated to produce a customized microscope for automated imaging of bright field and fluorescent images in multiwall plates.</gtr:partnerContribution><gtr:piContribution>Collaborated to produce a customized microscope for automated imaging of bright field and fluorescent images in multiwall plates</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>UoS Chen (HR)</gtr:description><gtr:id>00042AD1-4847-4979-AD6C-B1038357D1BD</gtr:id><gtr:impact>PMID: 21726921.</gtr:impact><gtr:outcomeId>D2vNgrwkSuW-1</gtr:outcomeId><gtr:partnerContribution>Expertise.</gtr:partnerContribution><gtr:piContribution>Provided expertise in zebrafish research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>epiGenesys Ltd</gtr:department><gtr:description>Epigenesys (SB)</gtr:description><gtr:id>2D324FE0-10B4-47A1-B491-050A1C7EB608</gtr:id><gtr:impact>The &amp;quot;Screener&amp;quot; database proposed is being evaluated and is ready to be further developed.</gtr:impact><gtr:outcomeId>DY2oQgpurzu-1</gtr:outcomeId><gtr:partnerContribution>EpiGenesys have proposed to expand the current capability of the screening unit database.</gtr:partnerContribution><gtr:piContribution>We have been involved in the specification and design of the database.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Seizure Liability Screen [AstraZeneca] VC</gtr:description><gtr:id>0F38E9CC-B9AF-4D4A-AC09-5EDDEC6E4DB9</gtr:id><gtr:impact>A grant application is being developed.</gtr:impact><gtr:outcomeId>KUVd96qaVdE-1</gtr:outcomeId><gtr:partnerContribution>AstraZeneca provided a set of known seizure-inducing compounds of varying potencies, which were evaluated in our novel assay for seizure liability. This work was able to identify seizure liability in some compounds that were not detected by AstraZeneca's existing assays. We concluded that for some compounds our assays are more sensitive than the one currently used by AstraZeneca</gtr:partnerContribution><gtr:piContribution>Carried out all of the experimental work to assay the compounds provided by AstraZeneca.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karus Therapeutics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HDAC inhibitor screen in Zebrafish [Karus Therapeutics] (VC)</gtr:description><gtr:id>0A8F2EB4-1577-4DEB-A95B-6991D53C9F8C</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>Cqmo3ygdjzG-1</gtr:outcomeId><gtr:partnerContribution>Characterisation of novel HDAC inhibitors as potential anti-epileptic drugs using molecularly focused screen in zebrafish.</gtr:partnerContribution><gtr:piContribution>Characterisation of novel HDAC inhibitors as potential anti-epileptic drugs using molecularly focused screen in zebrafish.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ASH Biotech</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Development of new equipment to increase throughput of drug screening methods in zebrafish (SB)</gtr:description><gtr:id>E8115937-046F-410D-9DE3-731D97D18F86</gtr:id><gtr:impact>Beta versions of two pieces of equipment are being evaluated. 
The Phenosight fluorescent plate reader that can take high speed images of transgenic zebrafish in multiwell plates and record the level of GFP in each embryo is now ready for marketing by ASH. This equipment is used extensively in the screening unit.
An embryo dispenser that can accurately aliquot embryos into 96 well plates is being optimized. The beta version works well for 48 hpf embryos.</gtr:impact><gtr:outcomeId>FLhBLyVBNkR-1</gtr:outcomeId><gtr:partnerContribution>Increasing throughput of drug screening methods in zebrafish.
The collaboration resulted in two new pieces of equipment being developed. The Phenosight imaging system has been modified over the past year and the software is much improved. The embryo dispenser has also improved but is still in the beta version.</gtr:partnerContribution><gtr:piContribution>Collaboration to produce new equipment for increasing throughput of drug screening methods in zebrafish. 
Over the past year we have contined to be involved in the product specification and design and testing of the equipment.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Festival of health, from head to toe (SR)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>591C994F-21C8-419C-96DC-B3A09EC1D075</gtr:id><gtr:impact>Enthused and educated public in the area of our research.

Future events planned.</gtr:impact><gtr:outcomeId>546490d2050909.22892739</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCAS Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B022F91E-CADA-4CCD-BDAE-C5E6F4F5B827</gtr:id><gtr:impact>Enthused and educated public in the area of our research.

Increased interest from students wishing to study science.</gtr:impact><gtr:outcomeId>546493be2eb082.47664880</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Engagement Competition (CP)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5C9591A5-E885-46EF-8749-A0FFA6BB52BF</gtr:id><gtr:impact>Yorkshire and North East Hub Public Engagement Competition, Newcastle-upon-Tyne. 
Gave a talk &amp;quot;Taking lessons from zebrafish to heart&amp;quot;.

NA</gtr:impact><gtr:outcomeId>pURiPhqAcBA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Using zebrafish for biomedical research (SB)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5DCCEAD2-3FEB-4BDD-A41E-7DE631473E95</gtr:id><gtr:impact>Increased interest in research.

Further visits planned in future years.</gtr:impact><gtr:outcomeId>54648f0d019119.31547401</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Innovations in Healthcare (VC)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6FB5852A-A294-4515-8D72-FDC8BC383D7C</gtr:id><gtr:impact>Enthused and educated public in the area of our research.

Tours of facilities arranged.</gtr:impact><gtr:outcomeId>546492753e46f0.21571660</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primary School Visit, Sheffield (SB)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>86E650B3-D648-4409-94AB-769179E5D79A</gtr:id><gtr:impact>Talk explaining why we use fish for research.

Children asked lots of questions.</gtr:impact><gtr:outcomeId>idSjP2x4zED</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Fish for Science website (CP/SB)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CAA20EA5-F841-4876-8A40-4D7169883721</gtr:id><gtr:impact>Production of the FishforScience website.

Awarded first Wednesday award by Understanding Animal Research. They quoted &amp;quot;This great website explains science very clearly and includes excellent teaching resources.&amp;quot;</gtr:impact><gtr:outcomeId>J9KUiQziHf1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Magna Science Centre</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>255B37E0-E8EF-4A5C-9B73-95770E66A5C2</gtr:id><gtr:impact>Young Chambers Science and Technology week at Magna Science Adventure Centre. 
&amp;quot;Fishing for clues: why medical researchers are glowing with excitement&amp;quot;. Members of the Centre for Developmental and Biomedical Genetics presented their research to approximately 200 GCSE students and members of the public. We demonstrated our research using live zebrafish embryos (fluorescence microscopy), together with video and written presentations.

Enthused students with out research.</gtr:impact><gtr:outcomeId>XqZTPxXGmDE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primary School visits - Sheffield (SB/CP)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7668F752-3C23-4BC6-87B1-DD32F87EBC58</gtr:id><gtr:impact>Three primary school visits - Sheffield.
Talk and activities explaining why we use fish for research, involving looking at fish embryos down the microscope for approximately 150 pupils.



We have been asked to come back to two schools to give the same presentation next year and also to work with the GCSE students.</gtr:impact><gtr:outcomeId>frHwVLCj531</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biology Workshop for sixth form students (SB)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>825E14FC-3961-434C-A0D6-4D65331A8FDD</gtr:id><gtr:impact>30 sixth form Biology students visited our department for a biology workshop, to learn about biomedical research in the university.
This workshop focused on how researchers use zebrafish in biomedical research. There was a presentation, a visit to the aquarium and observation of zebrafish embryos using microscopy. They also met informally with PhD students.

This is the second year we have run the workshop and we will run it again next year. We had very positive feedback from the students and teachers who all seemed to get a lot out of the day.</gtr:impact><gtr:outcomeId>csQL8ArM3tj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>King Edwards Sixth Form Biology Workshop (SB)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>20D2BACF-7061-4CD0-BFD6-C0C139B8EFB0</gtr:id><gtr:impact>Talk and activities explaining why we use fish for research, involving looking at fish embryos down the microscope for approximately 80 pupils.

2013 - 24 biology students attended a workshop on how researchers use zebrafish in biomedical research, as part of a day of talks and activities to inspire then to work hard at their A levels. 
They listened to a presentation, visited the aquarium and observed zebrafish embryos using microscopy.

Pupils asked lots of questions.
Feedback from a teacher - &amp;quot;The feedback from the students that attended your workshop was excellent, with students highlighting that the session was fun, informative and engaging - especially the research involving the zebra fish. It is clear that the students had a great insight into how research takes place and that they were very interested in looking at and studying the different stages of a cells development.&amp;quot;</gtr:impact><gtr:outcomeId>iqBD6EAVwkm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Disease, Development and Disco Fish - Pecha Kucha Night (CP)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0DAA6493-4CA7-4B7C-AD26-C8F9664283C2</gtr:id><gtr:impact>250 people attended a short talk, presented in a lively and engaging way explaining the use of zebrafish in medical research, under the heading Fish For Science.

Received excellent feedback from the audience and talked late into the night with many people about the research. Lots of interesting conversations on twitter followed from the talk.
Invited to give further talks at 'creative' nights in the city, including International Women's Day and TedX.</gtr:impact><gtr:outcomeId>JAEKtT2Jsvv</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Environmental Robots activity (SB)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9C1052B4-F957-40A8-945C-0072E9C99576</gtr:id><gtr:impact>Enthused and educated school children in the area of our research.

Similar future activities planned.</gtr:impact><gtr:outcomeId>5464943b42f3f8.82303450</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Researcher Night 2016 (J-PA)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A94DDB82-5705-400C-B270-4AF15FFF91CB</gtr:id><gtr:impact>Researchers night, a Festival of the Mind event, hosting talks, demonstrations and exhibitions based around University of Sheffield research. The event was open to all and is free to attend.</gtr:impact><gtr:outcomeId>589875436f84b3.20264815</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A Question of Taste; Hands on DNA post 16 workshop (SB/CP)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F48F09C3-F747-456F-A8F9-64B6721DF752</gtr:id><gtr:impact>A day long laboratory practical course in molecular biology and genetics for sixth form students.
36 Biology students from 2 schools attended the day and met scientists and learned about how we use molecular biology to understand genetics.
The workshop is offered with Science Brainwaves in collaboration with the University of Sheffield and the ASDC (The UK Association for Science and Discovery Centres), and supported by the Wellcome Trust. During this one-day workshop, students are able to explore the evolution of an unusual human trait where some people can taste a bitter chemical, whilst others cannot. Students use molecular biology techniques (DNA extraction, Polymerase Chain Reaction, restriction digestion and gel electrophoresis) to test their own DNA to compare their ability to taste a bitter chemical to the allele (version) of the responsible taste receptor gene.
The workshop is run on average once a month to a class of 12-24 students. There is a lot of opportunity for dialogue about the science, current research and the ethics of genetic testing. The students also see the University's working labs, as the workshop is run in our undergraduate teaching laboratories.

This was a second visit for the schools and there are visits from many local schools planned throughout the year.
The feedback forms show that around 70% of students are more likely to consider carrying on with science at degree level after attending the class. They also have a better understanding of what a scientist does. Most teachers have asked to return with the following year's group of students.</gtr:impact><gtr:outcomeId>kKT6Yvxe7Pc</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Discovery Night Festival of Science and Engineering (FvE/TW)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3A1D3221-38CB-41CA-B73C-BCC81B63982A</gtr:id><gtr:impact>Enthused and educated public in the area of our research.

Future participation planned.</gtr:impact><gtr:outcomeId>546491c2910c63.78437384</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - King Edward VII, Sheffield</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E786BF1F-7EA9-45A5-BD0A-C35C70FE89BD</gtr:id><gtr:impact>Presentation to year 11s about current research in Sheffield using non mammalian models, particularly Drosophila, to research human diseases.

Outcomes not yet determined. One student wrote on feedback form that s/he wants to be a PhD student.</gtr:impact><gtr:outcomeId>2D2AC8A390E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Singapore, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A* Research Partnership Studentship, Singapore (FvE/DG)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Agency for Science, Technology and Research (A*STAR)</gtr:fundingOrg><gtr:id>2D315B08-FDB3-4F3B-AE0C-F9B3F0E90A56</gtr:id><gtr:outcomeId>W42Ep1UEcT10</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>181295</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Intra European Fellowship (TW)</gtr:description><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>F3E62996-CCA9-49F2-9928-1EB5BF2240A1</gtr:id><gtr:outcomeId>PXDHw2avhBD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>502086</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Responsive mode Project Grant (TW)</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>78182E7A-C047-4FA2-AD52-D3B3443A0C51</gtr:id><gtr:outcomeId>NV1cpomSKJZ0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Departmental Studentship (TW)</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>University of Sheffield</gtr:fundingOrg><gtr:id>7F0ED5E6-2AB9-4483-8387-B8C9242D0CC3</gtr:id><gtr:outcomeId>54633efaad7ca6.39833648</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4825</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Action on Hearing Loss (TW)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Action on Hearing Loss</gtr:fundingOrg><gtr:id>24C08D09-B587-4500-8386-287E812D56B8</gtr:id><gtr:outcomeId>546b44f70313d8.86047054</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>16680</gtr:amountPounds><gtr:country>Singapore, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A* Research Attachment Programme, Singapore, Studentship (VC/PB)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Agency for Science, Technology and Research (A*STAR)</gtr:fundingOrg><gtr:id>E1B0583C-64D9-4217-A4F7-9E69794F0D35</gtr:id><gtr:outcomeId>q6ktPAKvMYp0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>85700</gtr:amountPounds><gtr:country>Mexico, United Mexican States</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship (VC/PM)/CONACYT (Mexico)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>National Council on Science and Technology (CONACYT)</gtr:fundingOrg><gtr:id>F9688CD2-06E4-4445-9504-02B6D0F79B0D</gtr:id><gtr:outcomeId>dmziN4dqt9J0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9446</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Sheffield Knowledge Transfer Fund [Karus] (VC)</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>University of Sheffield</gtr:fundingOrg><gtr:id>F78F2BFF-DC65-4B70-A740-B085F27E1656</gtr:id><gtr:outcomeId>N6MtcWsMEap0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Sheffield POC Fund [Chen] (HR)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>University of Sheffield</gtr:fundingOrg><gtr:id>EA27D545-048F-49BB-889E-4879028A98A4</gtr:id><gtr:outcomeId>EFCmCfVMRYQ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9519</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Sheffield KT Rapid Response Fund (VC)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>University of Sheffield</gtr:fundingOrg><gtr:id>CA98A10E-564D-4B21-9DA4-CF74FABE2B1A</gtr:id><gtr:outcomeId>PE5bCogaetp0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A re-purposing screen of a library of known bioactive compounds was screened for anticonvulsant activity in zebrafish embryos. Several compounds were identified that had not previously been shown to exhibit anti-convulsant activity.</gtr:description><gtr:grantRef>MC_G0802527</gtr:grantRef><gtr:id>B7F2BD18-9D33-4448-BEC4-E0BFADE88CA7</gtr:id><gtr:impact>Increased interest in the epilepsy research community in using the zebrafish as a model organism for epilepsy studies.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>coUwbEk7nhi</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Compounds with anticonvulsant activity in zebrafish (VC)</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Excellence with Impact Competition</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C3703CD1-ADD1-438C-8140-E802BDCF71B0</gtr:id><gtr:outcomeId>UMERDFiPGti</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The development of a new assay procedure for screening the effects of small molecules on Cryptococcus infection.</gtr:description><gtr:id>6C5C0E74-9A44-4A5F-828D-7056898C95B9</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>58987601c1f388.23550654</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cryptococcus infection assay (SJ)</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A novel model of epileptic seizure induction in zebrafish and a high throughput in situ hybridisation-based assay for seizure-resolving compounds have been developed. This model and the assay have been exploited to identify novel small molecules with anti-convulsant activity and may therefore have potential as anti-epileptic drugs.</gtr:description><gtr:id>4B3416B9-6E40-4D6F-BD96-8162E20BB626</gtr:id><gtr:impact>Selected Oral Presentation at EUFishBiomed COST-ACTION Workshop on Zebrafish Neurophysiology an Behaviour. Queen Mary University of London 2010.
HDAC inhibitor screen in zebrafish (Jan-June 2010). A collaboration with Karus Therapeutics funded by University of Sheffield Knowledge Transfer Project Fund.</gtr:impact><gtr:outcomeId>MGtMKTnBHTo</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Zebrafish epilepsy model (VC)</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An assay has been developed using transgenic zebrafish embryos that express GFP as a readout of the hypoxic signaling response. This model and the assay have been exploited to identify novel small molecules that show altered levels of GFP and may therefore have the potential to modulate the hypoxic response therapeutically. The method has been modified to a 96 well format to increase the throughput of screening.</gtr:description><gtr:id>C1D04E93-AA40-47C9-9793-0F45A542AD54</gtr:id><gtr:impact>FvE has developed collaborations with companies and other academics. The work has been presented at national and international meetings. Over 2000 small molecules have been screened.</gtr:impact><gtr:outcomeId>tjur9BsGS8P</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>A model of the hypoxia signaling response (FvE)</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An assay has been developed using zebrafish embryos to monitor the effects of small molecule libraries on bacterial growth and infection in vivo, using S. aureus. This model and the assay have been exploited to identify novel small molecules that improve infection outcome in vivo and may therefore be new therapeutics for S. aureus infectious disease. This method has been modified to a 96 well format to increase the throughput of screening.</gtr:description><gtr:id>E50AF33C-2D22-4ECB-9310-ED051C906B2A</gtr:id><gtr:impact>SR has developed collaborations with companies and other academics. The work has been presented at national and international meetings. Over 600 small molecules have been screened.The data have supported successful grant applications.</gtr:impact><gtr:outcomeId>cyEW1TjNZp1</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>A screen for in vivo modifiers of S. Aureus infection (SR)</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The drug screening facility is now able to perform all stages of the drug screening pipeline. We have assembled equipment for compound handling and embryo production through to multiple assay designs and hit detection, using a combination of automated and manual methods. In particular we have collaborated with Ash Biotech to increase throughput of embryos into assay plates and hit detection of fluorescent-based assays. We have increased embryo production using a miniMEPS tank (aquatichabitats), increased throughput for the in situ hybridization screen with an in situ hybridization machine (Intavis) and increased hit detection with a customized microscope with a motorized stage from Nikon that is specifically for multiwell plates and can be used for brightfield and fluorescent images. We can screen for behavioural changes using the Zebralab system from Viewpoint</gtr:description><gtr:id>022F16DD-590C-4A4F-891A-741CD7568AF0</gtr:id><gtr:impact>Seventeen assays have been completed using the facility and 10 others are in the pipeline.</gtr:impact><gtr:outcomeId>gtUSaBd97Bu</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Establishment of a drug screening facility (MP)</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An assay has been developed using zebrafish embryos to identify molecules that modify oligodendrocyte specification in vivo. Embryos were exposed to a drug library from 32 hpf to 52 hpf and then processed for in situ hybridisation staining of olig2 expression to assay for specification of oligodendrocyte precursor cells. This method has been modified to a 96 well format to increase the throughput of screening.</gtr:description><gtr:id>29004A44-1B38-436C-B64E-25272509A12A</gtr:id><gtr:impact>Over 2000 small molecules have been screened.</gtr:impact><gtr:outcomeId>cSt14mip4ja</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>A screen for modifiers of myelination (JW)</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The system developed is an end-to-end collection, processing and presentation system to support the other sections of this grant. The Data Organisation System (DOS) accepts raw images as produced by optical scanning equipment (primarily microscopes purchased through this award) as input and using an agreed code embedded into the filename or external metadata file. 

This award inspired the inception of a high performance data storage system in a collaborate effort between researchers from the MRC- CDBG, the Welcome Trust funded RNAi Facility and the Light Microscope Facility. The award used this hardware to implement an advanced file archiving / indexing system based on file fingerprinting such that only links to files are stored in the database and the files are stored on disk. Should the original files move then relinking them correctly in the database is a trivial matter.

In the prototype system researchers can view loaded images and assess the images as to whether the result is considered a 'Hit' or whether the compound was considered toxic. The structure of the database has been designed such that all results are attached to a central unique combination of Screen-Plate-compound for library-Well. This allows the database to record more complex quantitative parameters (eg. Fluorescence intensities, absence of fish features, links to external analyses).

Details of the compound libraries used for screening are loaded into the database with annotation pertinent to it stored for easy retrieval. 

A guiding principle of the database is that all the data either loaded in or collected by the interfaces (WWW, SQL access) is stored in flat files as far as is possible and that the entire database can be rebuilt from this using computer code. This allows ease of data integration with other external analysis packages and data entry using familiar spreadsheet interfaces. Template Spreadsheets have been constructed for this purpose that include rudimentary data validation.

Further different screens can then be linked together to form 'Investigations' such as primary screen, confirmation of Hits in a smaller replicate screen, a follow-up secondary screen and similar alternative results found in literature searches.

Software has been developed based on practical experience gained in the laboratory to identify problems in the library annotation (e.g. multiple compounds listed in the same well, duplicate compounds present, consistency checking of library rearrangements) and present these for further investigation / correction. 

The chemical structures of compounds in the library are being compared to both each other in the same library, to those in other libraries and publicly databases to identify similar compounds, allow decisions about the overlap in libraries and to improve annotation respectively. The analysis continues but there are clearly patterns within the comparison even when simple atoms connectivity is considered using Open Source Cheminformatics packages (OpenBabel) implementing classical distance measures. Through a collaboration at Erasmus MC (Rotterdam, The Netherlands) an optimally ordered heatmap using specialist software they have access to group compounds together into meaningful clusters has been prepared in preliminary form. This is useful for giving insight to non-domain specialists as to the relationships between compounds contained in libraries.</gtr:description><gtr:id>CB67BCDB-2F63-4E99-9C01-8623D19B649A</gtr:id><gtr:impact>Support of scientific screens internally.</gtr:impact><gtr:outcomeId>ADHYRDCgc1Q</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A data repository for high throughput screening data (MM)</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An assay has been developed using zebrafish embryos to monitor the effects of small molecules on semicircular canal formation, in vivo. Fish carrying mutations in a GPCR gene develop swollen ears as the semicircular canals fail to form correctly. This assay screens homozygous mutant embryos by in situ hybridization with a marker gene that is normally down-regulated in the ear during semicircular canal development, but remains up-regulated in mutant fish. Molecules that cause down-regulation of the marker gene and rescue the semicircular canal defect in mutant fish can be identified. This method has been modified to a 96 well format to increase the throughput of screening.</gtr:description><gtr:id>A0ACE495-A3DF-4845-A138-92E79BAC7D9A</gtr:id><gtr:impact>2000 small molecules have been screened; the data have supported a successful project grant application to the BBSRC.</gtr:impact><gtr:outcomeId>Bd4qteYEL7G</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>GPCR agonist drug screen (TW)</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An assay has been developed using transgenic zebrafish embryos, with GFP labelled neutrophils, to monitor the effects of small molecule libraries on the resolution of neutrophilic inflammation after tissue injury, in vivo. This model and the assay have been exploited to identify novel small molecules that reduce the numbers of neutrophils at the site of injury and may therefore be new therapeutics for inflammatory disease. The method has been modified to a 96 well format to increase the throughput of screening.</gtr:description><gtr:id>A51BCE6B-52F2-402C-8700-FB7F09718307</gtr:id><gtr:impact>The method has been published, SR has developed collaborations with companies and other academics. The work has been presented at national and international meetings. Over 5000 small molecules have been screened. A patent application covering this technology is in progress. The data have supported successful grant applications.</gtr:impact><gtr:outcomeId>VTWo2HdheM4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>A screen for inflammatory response (SR)</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An assay has been developed using wild type zebrafish embryos to monitor the effects of small molecules on semicircular canal formation, in vivo. Fish carrying mutations in a GPCR gene develop swollen ears as the semicircular canals fail to form correctly. Expression of a marker gene is normally down-regulated in the ear during semicircular canal development, but remains up-regulated in mutant fish. We have screened wild type embryos with a small molecule library and used in situ hybridisation of the marker gene to identify molecules that phenocopy the mutation. These compounds will be tested for an antagonistic role in the relevant signalling pathway. This method has been modified to a 96 well format to increase the throughput of screening.</gtr:description><gtr:id>A8166EFB-7B7F-415E-950C-0063211A924A</gtr:id><gtr:impact>2000 small molecules have been screened; the data have supported a successful project grant application to the BBSRC</gtr:impact><gtr:outcomeId>SfkPABqE6Dy</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>GPCR antagonist drug screen (TW)</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An assay has been developed using zebrafish embryos to monitor the
effects of a small molecule library of anti- prion compounds on zebrafish embryo survival, in vivo. This method has been modified to a 96 well format to increase the throughput of screening.</gtr:description><gtr:id>2F71F5BF-86B2-40F3-B4E2-A4C3B0F0964F</gtr:id><gtr:impact>Part of this work has been published (PMID:21726921).</gtr:impact><gtr:outcomeId>eRzmC83UmvE</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Toxicity of anti-prion compounds  (BC/HR)</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/21726921</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This protocol uses mesh bottomed plates (Millipore) throughout; from the addition of the drug, through the in situ hybridization machine (Intavis) and the image capture on a customized Nikon microscope. It has a number of advantages over existing methods including increased throughput, reduction in transferring of embryos to reduce the damage to the embryos and sample mixing errors, and high quality automated image capture for hit detection.</gtr:description><gtr:id>6E27F74C-7000-4FD6-9959-06C7DB96E8A4</gtr:id><gtr:impact>We have screened 8,000 compounds using this method.</gtr:impact><gtr:outcomeId>qS9y7Sdz3y2</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>The development of a new assay protocol for screening the effects of small molecules on zebrafish embryos by in situ hybridization (SB)</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic line of zebrafish and plasmid used to generate line.
Transgene provides live imaging information on neural activity within the developing CNS.</gtr:description><gtr:id>A2BD65EA-9318-481B-BBA1-2E9AF77ADC7E</gtr:id><gtr:impact>None yet; included as preliminary data in grant applications.</gtr:impact><gtr:outcomeId>VLH9Ky2bheq</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>NBT-GCaMP-3 transgenic zebrafish line and plasmid construct (VC)</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A method of analyzing the intensity of GFP fluorescence across the length of the zebrafish somites has been used to distinguish different patterns between wild type zebrafish and zebrafish carrying a mutation in the DMD gene. This method will be used to screen libraries of small molecules for rescue of the mutant phenotype which may lead to the identification of novel drugs for muscular dystrophy.</gtr:description><gtr:id>5FF03B60-92CF-4371-9F18-111C879A2F3F</gtr:id><gtr:impact>This work has been published in PLoS Currents: Muscular Dystrophy.
Lipscomb, L., Parkin, C.A., Juusola, M. &amp;amp; Winder, S.J.* (2011)</gtr:impact><gtr:outcomeId>ftCh5VGTcUr</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Quantification of muscle damage in a zebrafish muscular dystrophy model (SW)</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D944C176-56BB-4F31-88C5-2903EEE4262D</gtr:id><gtr:title>Building a zebrafish toolkit for investigating the pathobiology of epilepsy and identifying new treatments for epileptic seizures.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99553f9096428b41c4a9683098c0e4d6"><gtr:id>99553f9096428b41c4a9683098c0e4d6</gtr:id><gtr:otherNames>Cunliffe VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>589862401c1071.56094181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1793551-C71A-4AD5-A55A-DD5F07F026E3</gtr:id><gtr:title>A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb02da77cbb8764143c337ba82effe74"><gtr:id>fb02da77cbb8764143c337ba82effe74</gtr:id><gtr:otherNames>Da Costa MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_12940_20_24092880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEE57755-40E6-4759-8D5D-AA686A26AB49</gtr:id><gtr:title>The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c77d9fb04e6e8c9b5c3b222d9aedd208"><gtr:id>c77d9fb04e6e8c9b5c3b222d9aedd208</gtr:id><gtr:otherNames>Winder SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2157-3999</gtr:issn><gtr:outcomeId>pm_12940_20_22130468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2254697B-257F-46D0-9831-CB8B2370DB9B</gtr:id><gtr:title>Identification of benzopyrone as a common structural feature in compounds with anti-inflammatory activity in a zebrafish phenotypic screen.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dc100207245abff54644860ce102ccf"><gtr:id>9dc100207245abff54644860ce102ccf</gtr:id><gtr:otherNames>Robertson AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>585d3d9287d4e9.89763494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4FC2929-E667-49A4-811C-49CE85090D7C</gtr:id><gtr:title>Rx3 and Shh direct anisotropic growth and specification in the zebrafish tuberal/anterior hypothalamus.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d73c963de43897cc84d0920193e8bfab"><gtr:id>d73c963de43897cc84d0920193e8bfab</gtr:id><gtr:otherNames>Muthu V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>585d3d882ee1c3.00964250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E07B727-6F02-45BC-AFA2-89B936943A21</gtr:id><gtr:title>Discovery of 6-substituted indole-3-glyoxylamides as lead antiprion agents with enhanced cell line activity, improved microsomal stability and low toxicity.</gtr:title><gtr:parentPublicationTitle>European journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e4834f3e9d55cf47db288a6d7f493d2"><gtr:id>7e4834f3e9d55cf47db288a6d7f493d2</gtr:id><gtr:otherNames>Thompson MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0223-5234</gtr:issn><gtr:outcomeId>YteESsa1WoA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1935B9C7-A986-42CD-9FE2-73071768FC0D</gtr:id><gtr:title>Epilepsy research methods update: Understanding the causes of epileptic seizures and identifying new treatments using non-mammalian model organisms.</gtr:title><gtr:parentPublicationTitle>Seizure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99553f9096428b41c4a9683098c0e4d6"><gtr:id>99553f9096428b41c4a9683098c0e4d6</gtr:id><gtr:otherNames>Cunliffe VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1059-1311</gtr:issn><gtr:outcomeId>54648d3229a6d9.45947676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09A7CA4E-21FF-4FFA-8030-972FCAC37282</gtr:id><gtr:title>Zebrafish-based small molecule screens for novel cardiovascular drugs.</gtr:title><gtr:parentPublicationTitle>Drug discovery today. Technologies</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db8ce647d1a6068308048a4804264b08"><gtr:id>db8ce647d1a6068308048a4804264b08</gtr:id><gtr:otherNames>Novodvorsky P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1740-6749</gtr:issn><gtr:outcomeId>5461e6678a8037.18086736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB954F9E-5B91-4810-AF1A-23A627C0057C</gtr:id><gtr:title>Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>pm_12940_20_23683440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>549AE8DA-7EE7-42DA-A247-52E0ABFB18A9</gtr:id><gtr:title>Dasatinib as a treatment for Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/350cfd3c9488a709f1bca74dc11b42bd"><gtr:id>350cfd3c9488a709f1bca74dc11b42bd</gtr:id><gtr:otherNames>Lipscomb L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>589862b0df7e57.07610845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC98B715-0106-48C9-A72D-77B055CA2939</gtr:id><gtr:title>Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d51d9560ee35b1d0b928519f9f60f8"><gtr:id>26d51d9560ee35b1d0b928519f9f60f8</gtr:id><gtr:otherNames>Baxendale S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>doi_55f9849844d8c661</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_G0802527</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>986F1CAE-CC43-4D59-8F85-A91971E4C4BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Other</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>